Olangkaya, Sittie .

HRN: 28-71-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/18/2026
03/25/2026
IV
4.5G
Q6H
PNEUMONIA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: